Registro de Citas

Cita APA (7a ed.)
Deng, L., Peng, Y., Tan, C., Yi, L., Wang, H., Yuan, D., & Wen, Z. (2026). Telitacicept versus belimumab for the treatment of systemic lupus erythematosus: A network meta-analysis and cost-effectiveness analysis. BMJ Publishing Group.
Cita Chicago Style (17a ed.)
Deng, Li, Ye Peng, Chongqing Tan, Lidan Yi, Haihong Wang, Dou Yuan, y Zhenhua Wen. Telitacicept Versus Belimumab for the Treatment of Systemic Lupus Erythematosus: A Network Meta-analysis and Cost-effectiveness Analysis. BMJ Publishing Group, 2026.
Cita MLA (9a ed.)
Deng, Li, et al. Telitacicept Versus Belimumab for the Treatment of Systemic Lupus Erythematosus: A Network Meta-analysis and Cost-effectiveness Analysis. BMJ Publishing Group, 2026.
Precaución: Estas citas no son 100% exactas.